|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
19 February 2015 |
|
Main ID: |
NCT00331747 |
|
Date of registration:
|
30/05/2006 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Gait Evaluation in Multiple Sclerosis Patients Treated With Glatiramer Acetate
|
|
Scientific title:
|
Three Dimensional Gait Evaluation in Relapsing Remitting Multiple Sclerosis Patients Treated With Glatiramer Acetate |
|
Date of first enrolment:
|
May 2006 |
|
Target sample size:
|
20 |
|
Recruitment status: |
Recruiting |
|
URL:
|
http://clinicaltrials.gov/show/NCT00331747 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Israel
| | | | | | | |
|
Contacts
|
|
Name:
|
Uri Givon, MD |
|
Address:
|
|
|
Telephone:
|
+972-35304451 |
|
Email:
|
urigi@sheba.health.gov.il |
|
Affiliation:
|
|
|
|
Name:
|
Uri Givon, MD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Sheba Medical Center; Tel Aviv University |
|
|
Name:
|
Anat Achiron, MD, PhD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Sheba Medical Center; Tel Aviv University |
|
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Clinical diagnosis of multiple sclerosis
- EDSS less than 5.5
- No cognitive disability
Exclusion Criteria:
- EDSS over 5.5
- Inability to cooperate with gait analysis
Age minimum:
18 Years
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Multiple Sclerosis
|
|
Intervention(s)
|
|
Drug: Glatiramer acetate
|
|
Primary Outcome(s)
|
|
Computerized gait analysis: at the beginning of treatment and after 1 year
|
|
Secondary ID(s)
|
|
SHEBA-05-3985-UG-CTIL
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|